Grade | AAST disease grade | Corres- ponding Tokyo grade | Management | Ref- erences |
I | Local disease; confined to the organ; minimal abnormality | I | Operative (laparoscopic if possible) if within 10 days of onset of symptoms; consider antibiotics±percutaneous cholecystostomy tube if beyond 10 days | 7 9 10 11 |
II | Local disease; confined to the organ; severe abnormality | II | Operative (laparoscopic if possible; consideration of conversion to open/subtotal cholecystectomy as dictated by intraoperative findings); antibiotics and percutaneous cholecystostomy tube may be considered, but evidentiary support for populations who may benefit from this approach is sparse | 7 9 10–12 |
III | Beyond the organ; locally advanced only | II | Operative (laparoscopic if possible; consideration of conversion to open/subtotal cholecystectomy as dictated by intraoperative findings); antibiotics and percutaneous cholecystostomy tube may be considered, but evidentiary support for populations who may benefit from this approach is sparse | 7 9 10–12 |
IV | Beyond the organ; regional extension | II | Operative (laparoscopic if possible; consideration of conversion to open/subtotal cholecystectomy as dictated by intraoperative findings) | 7 9 10–12 |
V | Beyond the organ; widespread involvement | III | Operative (laparoscopic if possible; consideration of open approach in the setting of septic shock; strong consideration of conversion to open/subtotal cholecystectomy as dictated by intraoperative findings) | 7 9 10–12 |